That's where investors in ADN have an edge. Very-high IRR (i.e. low capital intensity) means the probability of dilution is significantly reduced.
ADN aren't like HPA and Lithium projects that have combined CAPEX and working capital burdens in excess of $200M.
Ann: Appendix 2A - Exercise of Options, page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.14M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $13.76K | 1.637M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 17425801 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 16335345 | 19 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ADN (ASX) Chart |